Skip to main content

Darlington

Final policy now available via NTAG website.


FOI acknowledgement:

Our reference: D1437 - Acknowledgement 

Thank you for your Freedom of Information (FOI) request, received at Darlington CCG.

Your request is being dealt with under the terms of the Freedom of Information Act 2000 and will be answered within twenty working days.

In some circumstances a fee may be payable. If that is the case, I will let you know. A fees notice will be issued to you if appropriate. You will be required to pay the relevant fee before we will proceed to deal with your request.

If you have any queries about this request or wish to contact us again, please email the address above and the message will be forwarded appropriately. Please remember to quote the reference number above in any future communications.

I'm still waiting for the official response, but this response has been sent to a Libre group member (thanks Rachel!):


I have contacted my colleague in Medicines Management and he has advised me that the CCG and practices are aware of the updated guidance on flash glucose monitoring from NHS England but are waiting for further advice from a regional body regarding the fairest and most efficient way to implement it. This advice will come from the Northern Treatment Advisory Group (NTAG) which will be published this week and it is hoped it will set out the mechanism for patients to obtain FreeStyle Libre.

At present Darlington surgeries have been advised not to prescribe FreeStyle Libre until the regional position is clear which includes how the shared responsibilities for monitoring the response to the device will be managed between specialist diabetes clinics and the patient’s GP.


Once this advice is available and approved by the CCG they will be in a position to provide further information to you.

FOI Response


Comments

Popular posts from this blog

Big Announcement - Libre Funding

NEWS RELEASE Embargoed 00:01 November 14 NHS TO PROVIDE LIFE CHANGING GLUCOSE MONITORS FOR TYPE 1 DIABETES PATIENTS Tens of thousands of people with Type 1 diabetes across the country will benefit from life changing glucose monitors on the NHS. To coincide with World Diabetes Day, Simon Stevens, Chief Executive of NHS England, is announcing action to end the current variation patients in some parts of the country are facing to access Freestyle Libre. The wearable sensor does away with the need for inconvenient and sometimes painful finger prick blood tests by relaying glucose levels to a smart phone or e-reader. NHS England will ensure the device, which is the size of a £2 coin and sits on the arm, is available on prescription for all patients who qualify for it in line with NHS clinical guidelines. From April 2019, these patients will be able to receive it on prescription from their local GP or diabetes team helping them to better manage their blood sugar levels. It comes as the NHS seeks t…

The CCG Project!

In order to find out the situation around the country for Libre prescribing now that the national policy has been published, I have made the decision to contact many of them to find out their plans.  I have arbitrarily chosen to contact all English CCGs that in December 2018 prescribed Libre via Primary Care to less than 5% of their population (and one specific request from a group member).  I had hoped this would be a small list, but there are 135 CCGs on the list.  I may have bitten off more than I can chew, but I'm committed to doing this and feeding back.  It worked before and hopefully this level of scrutiny will bring similar results.

Below is a screenshot of the base document I am sending to each of the CCGs - it has some fields that are merge fields, so don't worry about the brackets and codes in the document (I found a typo, which has now been corrected too)
The major piece of work with respect to this is finding the right person to contact.  However, I have some m…

NHS England Libre Policy

The NHS England policy for prescribing of Freestyle Libre has now been released.  There is a link to the document at the bottom of the page, but the key part of the policy can be viewed below.  Here is the Link to Policy